SecBot SecBot
8-K ·Filed May 26, 2026

USAQ

QHSLab, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed5mo ago SEC0001493152-26-025170
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

The 57% YoY revenue growth is a positive operational data point, but it's a single month of unaudited data with no profitability or guidance context. Monitor the Q2 2026 10-Q for sustained revenue trends and margin progression. The PAN initiative is early-stage with no revenue contribution yet — watch for practice activation metrics in future filings.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
USAQ ▼ -24.57% at T+60d
NEUTRAL call -24.57% · α vs SPY -27.29% · entry $0.4640 → $0.3500
Entry = T+0 close
May 26, 2026
via day close
T+1d
0.00%
call 0.00% · α +0.04%
$0.4640
settled 5mo ago
T+5d
+21.98%
call +21.98% · α +20.90%
$0.5660
settled 5mo ago
T+20d
-34.91%
call -34.91% · α -32.97%
$0.3020
settled 4mo ago
T+60d
-24.57%
call -24.57% · α -27.29%
$0.3500
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

QHSLab reported unaudited April 2026 revenue of approximately $325,889, up 57% YoY from $207,538, and announced a new Practice Access Network (PAN) initiative to accelerate Q-Connect platform adoption. The company will also present at the Planet MicroCap Showcase in June 2026. While the revenue growth is strong, the filing is a routine operational update with no guidance or material financial data beyond a single month's unaudited revenue.

Key Facts

  • Unaudited April 2026 revenue of approximately $325,889, up 57% YoY from $207,538
  • Introduced QHS Practice Access Network (PAN), a relationship-driven independent representative initiative to accelerate Q-Connect platform adoption
  • Company will present at the 2026 Planet MicroCap Showcase conference June 16-18, 2026
  • Filing is under Item 7.01 (Regulation FD Disclosure) — information is furnished, not filed

Financial Impact

April 2026 unaudited revenue of ~$325,889 vs $207,538 in April 2025, a ~57% YoY increase

revenue

Risk Factors

  • Single month of unaudited revenue may not be indicative of full-quarter or annual trends
  • PAN initiative is newly introduced with no track record or quantified pipeline
  • OTC-traded microcap with limited liquidity and analyst coverage

Market Snapshot

Exchange
OTC
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-025170
Exhibit: ex99-1.htm0001493152-26-025170
Document: 0001493152-26-025170-index-headers.html0001493152-26-025170
Document: 0001493152-26-025170-index.html0001493152-26-025170
Document: 0001493152-26-025170.txt0001493152-26-025170
5 reports for USAQ
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for USAQ — sortable, filterable
TypeNow
Sep 17, 2026
5w ago
SC 13G
NEUTRAL ★ 3/10
$0.3500awaiting T+60—$0.3210 (−8.29%)
Aug 3, 2026
12w ago
8-K
BULLISH ★ 6/10
$0.3690 $0.3000▼ −18.70%▼ −20.48%$0.3210 (−13.01%)
Jun 17, 2026
18w ago
8-K
NEUTRAL ★ 3/10
$0.3500 $0.3000▼ −14.29%▼ −17.70%$0.3210 (−8.29%)
May 26, 2026
22w ago
8-K
NEUTRAL ★ 4/10
$0.4640 $0.3500▼ −24.57%▼ −27.29%$0.3210 (−30.82%)
Apr 21, 2026
27w ago
8-K
BULLISH ★ 7/10
$0.6790 $0.3170▼ −53.31%▼ −60.21%$0.3210 (−52.72%)
Showing 5 of 5

US Market Status

Market Closed — Opens Thu (11h 47m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 26, 2026